schemaVersion:

Form C: Filer Information

Filer CIK:
0001651239 
Filer CCC:
XXXXXXXX 
Period:

12-31-2021 

Is this a LIVE or TEST Filing?Radio button checked LIVE Radio button not checked TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?Checkbox not checked
Would you like a Return Copy?Checkbox not checked

Submission Contact Information

Name:
 
Phone Number:
 
Contact E-Mail Address:
 
Notify via Filing Website only?Checkbox not checked

Form C: Issuer Information

Issuer Information

Name of Issuer:

Quadrant Biosciences Inc 

Legal Status of Issuer:

Form:

Corporation 

Jurisdiction of Incorporation/Organization:

DELAWARE  

Date of Incorporation/Organization:

03-13-2015 

Physical Address of Issuer:

Address 1:

505 IRVING AVENUE 

Address 2:

SUITE 3100 A-B 

City:

SYRACUSE 

State/Country:

NEW YORK  

Mailing Zip/Postal Code:

13210 

Website of Issuer:

quadrantbiosciences.com 

Is there a Co-issuer? Radio button not checked Yes Radio button checked No

Form C: Offering Information

Offering Information

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:

126.00 

Total Assets Most Recent Fiscal Year-end:

38227705.00 

Total Assets Prior Fiscal Year-end:

25139833.00 

Cash and Cash Equivalents Most Recent Fiscal Year-end:

8116233.00 

Cash and Cash Equivalents Prior Fiscal Year-end:

9743455.00 

Accounts Receivable Most Recent Fiscal Year-end:

13651979.00 

Accounts Receivable Prior Fiscal Year-end:

1354350.00 

Short-term Debt Most Recent Fiscal Year-end:

7393024.00 

Short-term Debt Prior Fiscal Year-end:

10985782.00 

Long-term Debt Most Recent Fiscal Year-end:

7016522.00 

Long-term Debt Prior Fiscal Year-end:

5707571.00 

Revenue/Sales Most Recent Fiscal Year-end:

60519179.00 

Revenue/Sales Prior Fiscal Year-end:

11801123.00 

Cost of Goods Sold Most Recent Fiscal Year-end:

33466238.00 

Cost of Goods Sold Prior Fiscal Year-end:

8609760.00 

Taxes Paid Most Recent Fiscal Year-end:

0.00 

Taxes Paid Prior Fiscal Year-end:

0.00 

Net Income Most Recent Fiscal Year-end:

12247807.00 

Net Income Prior Fiscal Year-end:

1732052.00 

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

Quadrant Biosciences Inc. 

Signature:

/s/ Richard Uhlig 

Title:

Chief Executive Officer 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Richard Uhlig 

Title:

Chief Executive Officer, Chairman 

Date:

05-02-2022 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Richard Bongo 

Title:

Chief Financial Officer, Principal Accounting Officer, Director 

Date:

05-02-2022 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ James Croke 

Title:

Director 

Date:

05-02-2022 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Peter Cohen 

Title:

Director 

Date:

05-02-2022 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Ira Fedder MD 

Title:

Director 

Date:

05-02-2022 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Andrew Rock 

Title:

Director 

Date:

05-02-2022 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Mary Ann Tyszko 

Title:

Director 

Date:

05-02-2022